Shares of ResMed Inc. RMD shed 1.42% to $254.40 Friday, on what proved to be an all-around rough trading session for the ...

ResMed trades at $254.11 per share and has stayed right on track with the overall market, gaining 8.9% over the last six ...

The first blue chip ASX 200 share that could be a buy is REA Group. It is the dominant player in Australia's online real ...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One ...

This ASX 200 share is quietly becoming a global leader in diagnostic imaging software. Its flagship product, Visage 7, ...

Resmed announced that it will release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025, after the market closes. Following the release, management ...

SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31 ...

ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and ...

Australia’s sharemarket is about to notch a third straight year of falling profits and 2026 doesn’t look much better. But ...

If you spend any time in post-acute care today, whether in a skilled nursing facility, an assisted living community, or a ...